Vicapsys Life Sciences, Inc.
OTC:VICP
2 (USD) • At close November 9, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2009 | 2008 | |
---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||
Current Assets: | |||||||||
Cash & Cash Equivalents
| 0.009 | 0.014 | 0.217 | 0.001 | 0.264 | 0.086 | 0.548 | 0.122 | 0.065 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 0.009 | 0.014 | 0.217 | 0.001 | 0.264 | 0.086 | 0.548 | 0.122 | 0.065 |
Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.091 | 0.475 |
Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.597 | 0.079 |
Other Current Assets
| 0.03 | 0.058 | 0.005 | 0 | 0 | 0 | 0.016 | 0.654 | 0.079 |
Total Current Assets
| 0.04 | 0.072 | 0.223 | 0.001 | 0.264 | 0.086 | 0.563 | 1.867 | 0.62 |
Non-Current Assets: | |||||||||
Property, Plant & Equipment, Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0.295 | 0.348 | 0.428 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0 | 0 | 0.372 | 0.403 | 0.434 | 0.466 | 0.18 | 0 | 0 |
Goodwill and Intangible Assets
| 0 | 0 | 0.372 | 0.403 | 0.434 | 0.466 | 0.18 | 0 | 0 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | 0.05 | -0 | 0 | 0 | 0.244 | 0.038 | 0.016 | 0.021 |
Total Non-Current Assets
| 0 | 0.05 | 0.372 | 0.403 | 0.434 | 0.71 | 0.514 | 0.363 | 0.449 |
Total Assets
| 0.04 | 0.072 | 0.594 | 0.404 | 0.698 | 0.796 | 1.077 | 2.231 | 1.069 |
Liabilities & Equity: | |||||||||
Current Liabilities: | |||||||||
Account Payables
| 1.499 | 0.635 | 0.488 | 0.508 | 0.396 | 0.35 | 0.506 | 0 | 0 |
Short Term Debt
| 0.354 | 0 | 0 | 0 | 0 | 0 | 0 | 1.431 | 0.845 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| -0.354 | 0 | 0 | 0 | 0 | 0 | 0 | 0.252 | 0.488 |
Other Current Liabilities
| 1.054 | 0.387 | 0.228 | 0.345 | 0 | 0.7 | 0.523 | 1.963 | 0.804 |
Total Current Liabilities
| 1.968 | 1.023 | 0.716 | 0.853 | 0.396 | 1.05 | 1.03 | 3.646 | 2.137 |
Non-Current Liabilities: | |||||||||
Long Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.319 | 0.414 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 0 | 0.908 | 0 | 0 | 0 | 0 | 0 | 1.319 | 0.414 |
Total Liabilities
| 1.968 | 1.023 | 0.716 | 0.853 | 0.396 | 1.05 | 1.03 | 4.965 | 2.551 |
Equity: | |||||||||
Preferred Stock
| 0 | 0 | 0 | 0.007 | 0.007 | 0.007 | 0.007 | 0 | 0 |
Common Stock
| 0.032 | 0.031 | 0.02 | 0.017 | 0.017 | 0.01 | 0.012 | 0.035 | 0.035 |
Retained Earnings
| -16.3 | -15.118 | -14.13 | -13.893 | -13.127 | -11.557 | -9.355 | -5.907 | -4.237 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0.001 | 0.011 | 0.001 | 0.001 | 0.004 | 0.003 | 0 | 0 |
Other Total Stockholders Equity
| 28.679 | 14.135 | 13.988 | 13.418 | 13.403 | 11.282 | 9.382 | 3.139 | 2.72 |
Total Shareholders Equity
| -1.929 | -0.951 | -0.122 | -0.449 | 0.302 | -0.254 | 0.047 | -2.734 | -1.482 |
Total Equity
| -1.929 | -0.951 | -0.122 | -0.449 | 0.302 | -0.254 | 0.047 | -2.734 | -1.482 |
Total Liabilities & Shareholders Equity
| 0.04 | 0.072 | 0.594 | 0.404 | 0.698 | 0.796 | 1.077 | 2.231 | 1.069 |